透過您的圖書館登入
IP:3.17.110.58
  • 期刊

真正的微創手術:經導管二尖瓣修補術

摘要


美國FDA核准了“經導管二尖瓣修補術"可以使用在高手術風險的原發性二尖瓣逆流病人身上。在長期的追蹤之下,這些病人二尖瓣逆流的程度皆可有效降低,而病人的症狀也都獲得了持續性的改善。基於這些有效的證據,這項技術也會朝向使用在低度手術風險或甚至只有中等程度二尖瓣逆流的病人身上,不斷邁進。

參考文獻


Rahul PS, Moody M, Saibal K. An overview of the mitraclip procedure: indications, procedural characteristics, and clinical outcomes. J Stru Heart Dis 2015;1;127-37.
Yanagawa B, Latter D, Verma S. Year in review: mitral valve surgery. Curr Opin Cardiol 2016;31:148-53.
Levi N, Meerkin D. Transcatheter repair of the mitral valve: relevant pathophysiology, investigation and management. Can J Cardio 2021;SO828-282x:00159-9.
Xavier F, Rodrigo EL, Fernando CH, et al. Percutaneous mitral valve repair: outcome improvement with operator experience and a second-generation device. J Clin Med 2021;10:734.

延伸閱讀